AtriCure, Inc.
ATRC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,435 | $1,653 | $2,030 | $3,133 |
| - Cash | $123 | $84 | $58 | $44 |
| + Debt | $77 | $74 | $75 | $76 |
| Enterprise Value | $1,389 | $1,643 | $2,046 | $3,165 |
| Revenue | $465 | $399 | $330 | $274 |
| % Growth | 16.5% | 20.8% | 20.4% | – |
| Gross Profit | $348 | $300 | $246 | $206 |
| % Margin | 74.7% | 75.2% | 74.4% | 75% |
| EBITDA | -$19 | -$8 | -$30 | $66 |
| % Margin | -4% | -2% | -8.9% | 24% |
| Net Income | -$45 | -$30 | -$46 | $50 |
| % Margin | -9.6% | -7.6% | -14.1% | 18.3% |
| EPS Diluted | -0.95 | -0.66 | -1.02 | 1.09 |
| % Growth | -43.9% | 35.3% | -193.6% | – |
| Operating Cash Flow | $12 | $4 | -$22 | -$14 |
| Capital Expenditures | -$23 | -$42 | -$17 | -$10 |
| Free Cash Flow | -$11 | -$38 | -$39 | -$24 |